Indaptus Therapeutics, Inc.
INDP
$2.16
$0.168.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.25% | -7.71% | -5.15% | 2.60% | 1.21% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -100.00% | -41.67% | -16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.12% | -33.12% | -34.65% | -9.03% | 18.17% |
| Change in Net Operating Assets | -130.95% | -56.13% | 566.75% | 175.72% | 333.37% |
| Cash from Operations | -30.35% | -17.44% | -8.52% | 8.07% | 11.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 152.77% | 2,348.15% | 2,476.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -80.09% | -4,911.63% | -5,270.00% | -- | -- |
| Cash from Financing | 357.33% | 3,805.70% | 2,299.78% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.88% | 78.80% | -299.24% | -302.81% | -192.84% |